skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Academic Search Premier remover idioma: Russo remover Science Citation Index Expanded (Web of Science) remover ClinicalKey remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

Mega, JL, MD ; Braunwald, E, Prof ; Mohanavelu, S, MS ; Burton, P, MD ; Poulter, R, MB ; Misselwitz, F, MD ; Hricak, V, Prof ; Barnathan, ES, MD ; Bordes, P, MD ; Witkowski, A, Prof ; Markov, V, Prof ; Oppenheimer, L, PhD ; Gibson, CM, MD

The Lancet (British edition), 2009-07, Vol.374 (9683), p.29-38 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

Staessen, Jan A ; Fagard, Robert ; Thijs, Lutgarde ; Celis, Hilde ; Arabidze, Guramy G ; Birkenhäger, Willem H ; Bulpitt, Christopher J ; de Leeuw, Peter W ; Dollery, Colin T ; Fletcher, Astrid E ; Forette, Françoise ; Leonetti, Gastone ; Nachev, Choudomir ; O' Brien, Eoin T ; Rosenfeld, Joseph ; Rodicio, José L ; Tuomilehto, Jaakko ; Zanchetti, Alberto

The Lancet (British edition), 1997-09, Vol.350 (9080), p.757-764 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Smolen, Josef S, Prof ; Nash, Peter, MD ; Durez, Patrick, Prof ; Hall, Stephen, MD ; Ilivanova, Elena, MD ; Irazoque-Palazuelos, Fedra, MD ; Miranda, Pedro, MD ; Park, Min-Chan, MD ; Pavelka, Karel, Prof ; Pedersen, Ronald, MS ; Szumski, Annette, MS ; Hammond, Constance, BS ; Koenig, Andrew S, DO ; Vlahos, Bonnie, BSN

The Lancet (British edition), 2013-03, Vol.381 (9870), p.918-929 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Gianni, Luca, Dr ; Eiermann, Wolfgang, MD ; Semiglazov, Vladimir, MD ; Manikhas, Alexey, MD ; Lluch, Ana, MD ; Tjulandin, Sergey, MD ; Zambetti, Milvia, MD ; Vazquez, Federico, MD ; Byakhow, Mikhail, MD ; Lichinitser, Mikhail, MD ; Climent, Miguel Angel, MD ; Ciruelos, Eva, MD ; Ojeda, Belén, MD ; Mansutti, Mauro, MD ; Bozhok, Alla, MD ; Baronio, Roberta, MSci ; Feyereislova, Andrea, MD ; Barton, Claire, MD ; Valagussa, Pinuccia ; Baselga, Jose, MD

The Lancet (British edition), 2010-01, Vol.375 (9712), p.377-384 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.